This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Jordanova, E. S. Articles by Fleuren, G. J. Search for Related Content PubMed PubMed Citation Articles by Jordanova, E. S. Articles by Fleuren, G. J.

Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8⁺/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?

Authors' Affiliations: Departments of ¹ Pathology, ² Gynecology, and ³ Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands and ⁴ Academic Department of Clinical Oncology, Institute of Infection, Immunity and Inflammation, University of Nottingham, City Hospital, Nottingham, United Kingdom

Requests for reprints: Arko Gorter, Department of Pathology, Leiden University Medical Center, L1Q, P1-32, Albinusdreef 2, 2333ZA Leiden, the Netherlands. Phone: 31-71-5266631; Fax: 31-71-5248158; E-mail: a.gorter{at}lumc.nl.

Purpose: To investigate the effect of intraepithelial tumor-infiltrating lymphocytes (ieTIL) and their ligands expressed by cervical tumor cells on the outcome of cervical cancer patients.

Experimental Design: The prognostic value of ieTILs was investigated in 115 cases of cervical cancer. T-cell subsets, CD57⁺ cells, and regulatory T cells (Treg) were enumerated. The associations of these different ieTIL subtypes with human leukocyte antigen (HLA) class I and MHC class I chain-related molecule A (MICA) expression were determined in relation to clinical variables and patient survival.

Results: Survival analysis showed that a high number of intraepithelial Treg (FoxP3⁺), a low CD8⁺/regulatory T-cell ratio, and a weak HLA-A expression were all associated with worse survival (P = 0.034, 0.025, and 0.033, respectively, log-rank test). Further stratification of patient groups based on HLA-A-MICA expression and HLA-A-MICA-CD8⁺/Treg ratio revealed an even poorer survival (P = 0.005). In a multivariate Cox analysis, low CD8⁺/Treg ratio (P = 0.047), weak HLA-A-MICA expression (P = 0.003), and weak HLA-A-MICA expression combined with low CD8⁺/Treg ratio (P = 0.002) were all found to be independent unfavorable prognostic predictors in cervical carcinoma (hazard ratios, 2.7, 4.0, and 4.9, respectively).

Conclusion: Weak HLA-A-MICA expression combined with low CD8⁺/Treg ratio reveals a patient group with the poorest survival in cervical cancer. As a single variable, low CD8⁺/Treg ratio was a significant independent unfavorable prognostic factor.